646482-93-1

Basic information

• Product Name: Acetic acid, [(2,5-dihydro-2-methyl-2-octyl-5-oxo-3-thienyl)oxy]-, 2-(4-chlorophenyl)hydrazide
• CAS NO: 646482-93-1
• Molecular Formula: C21H29ClN2O3S
• Molecular Weight: 424.992
• Mol File: 646482-93-1.mol

Chemical Properties

• CAS DataBase Reference: Acetic acid, [(2,5-dihydro-2-methyl-2-octyl-5-oxo-3-thienyl)oxy]-, 2-(4-chlorophenyl)hydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, [(2,5-dihydro-2-methyl-2-octyl-5-oxo-3-thienyl)oxy]-, 2-(4-chlorophenyl)hydrazide(646482-93-1)
• EPA Substance Registry System: Acetic acid, [(2,5-dihydro-2-methyl-2-octyl-5-oxo-3-thienyl)oxy]-, 2-(4-chlorophenyl)hydrazide(646482-93-1)

Safety Data

• Hazardous Substances Data: 646482-93-1(Hazardous Substances Data)

Upstream product

• 646483-06-9 (+/-)-2-acetylsulfanyl-2-methyldecanoic acid ethyl ester 
• 646483-08-1 (+/-)-4-hydroxy-5-methyl-5-octyl-5H-thiophen-2-one 
• 71091-89-9 n-octyl triflate 
• 1024810-14-7 2,2,4-trimethyl-4-octyl-[1,3]oxathiolan-5-one 
• 111-87-5 octanol 
• 1073-70-7 4-chlorophenylhydrazine hydrochloride 
• 646483-11-6 (+/-)-(5-methyl-5-octyl-2-oxothiophen-4-yloxy)acetic acid 

Relevant articles and documents

NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME

Compounds having the following general formula, pharmaceutical compositions comprising the compounds, and methods of treating cancer, obesity, and microbial infections using such compositions: wherein: R1 = H, C1-C20 alkyl, cycloalkyl, alkenyl, aryl, aryl

NOVEL COMPUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME

A pharmaceutical composition comprising a phamaceurtical diluent and a compound of formula IV wherein R21= H, C1-C20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, -CH2OR25, -C(O)R25, -CO(O)R25, -C(O)NR25R26, -CH2C(O)R25, or -CH2C(O)NHR25, where R25 and R26 are each independently H, C1-C10 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing one or more halogen atoms. R22 = -OH, -OR27, -OCH2C(O)R27, -OCH2C(O)NHR27, -OC(O)R27, -OC(O)OR27, -OC(O)NHNH-R5, or -OC(O)NR27R28, where R27 and R28 are each independentlyH, C1 -C20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, and where R27 and R28 can each optionally contain halogen atoms; R23 and R24, the same or different from each other, are C1-C20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl. Methods of using such formulations for the treatment of cancer, to effect weight loss, to treat microbially-based infections, to inhibit neuropeptide-Y and/or fatty acid synthase, and to stimulate CPT-1.